Therapeutic potential of a novel hybrid protein: Mitigating allergy and airway remodeling in chronic asthma models induced by Dermatophagoides pteronyssinus
Molecular Immunology · 2024-11 · 175 · 121-131
DOI: 10.1016/j.molimm.2024.09.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Immunology, 2024-11. Verfasst von Antônio Márcio Santana Fernandes und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Allergology and Acarology (LAA), Institute of Health Sciences, Federal University of Bahia, Salvador, BA, Brazil. Electronic address: m…. Hauptthemen laut MEDLINE: Airway Remodeling, Dermatophagoides pteronyssinus, Asthma, Disease Models, Animal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado da Bahia.
Abstract (Originalsprache)
BACKGROUND: The house-dust mite Dermatophagoides pteronyssinus is a key trigger of allergic asthma. Therefore, it is essential to develop new vaccines that can alter inflammatory processes and airway remodeling. The goal of this study was to test the hypoallergenic and immunogenic characteristics of the hypoallergen rDer p 2231 in a murine model of chronic asthma induced by D. pteronyssinus. METHODS: For this, we measured the levels of IgE, IgG1, IgG2a, and cytokines produced by mice receiving the rDer p 2231 protein. Histopathological parameters of the chronic inflammatory response were also investigated by assessing inflammation and airway remodeling. RESULTS: rDer p 2231 given as a therapeutic vaccine, led to a reduction in the production of IgE, eosinophils, and neutrophils, a lower activity of eosinophilic peroxidase in the airways, and an increase in the production of IgG1 and IgG2a antibodies. IgG antibodies blocked IgE binding to parental allergens in sera from atopic patients. Splenocytes, BALF, and lung from mice treated with rDer p 2231 secreted higher levels of Th1 and regulatory cytokines, as well as reduced levels of Th2 cytokines. Histopathological investigation of the lower airways demonstrated reductions in the thickness of the bronchiolar smooth muscle layer, in the subepithelial fibrosis, and in the goblet cells hyperplasia. CONCLUSIONS: Our preclinical studies suggest that rDer p 2231 is a promising candidate for the treatment of D. pteronyssinus allergy, as the hypoallergen has demonstrated the ability to reduce IgE production, induce specific blocking antibodies, restore and balance Th1/Th2 immune responses, and significantly reduce airway remodeling factors. However, additional clinical studies are needed to more accurately assess the efficacy and safety of rDer p 2231 as a vaccine against D. pteronyssinus-induced allergy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Allergology and Acarology (LAA), Institute of Health Sciences, Federal University of Bahia, Salvador, BA, Brazil. Electronic address: marciofernandes14@gmail.com.
- Laboratory of Allergology and Acarology (LAA), Institute of Health Sciences, Federal University of Bahia, Salvador, BA, Brazil; Post-Graduate Program in Immunology (PPGIm) of the Federal University of Bahia, Salvador, B…
- Laboratory of Allergology and Acarology (LAA), Institute of Health Sciences, Federal University of Bahia, Salvador, BA, Brazil. Electronic address: elissfontess@gmail.com.
- Laboratory of Allergology and Acarology (LAA), Institute of Health Sciences, Federal University of Bahia, Salvador, BA, Brazil. Electronic address: leonardofsantiago@gmail.com.
- Laboratory of Allergology and Acarology (LAA), Institute of Health Sciences, Federal University of Bahia, Salvador, BA, Brazil. Electronic address: emilia_mandrade@hotmail.com.
- Laboratory of Allergology and Acarology (LAA), Institute of Health Sciences, Federal University of Bahia, Salvador, BA, Brazil. Electronic address: alvesvitor@usp.br.
Förderung
- Fundação de Amparo à Pesquisa do Estado da Bahia
Zitieren
APA
Fernandes, A. M. S., da Silva, E. S., Silva, R. C., Silveira, E. F., Santiago, L. F., de Andrade Belitardo, E. M. M., Alves, V. D. S., Bôas, D. S. V., de Freitas, L. A. R., Ferreira, F., Jacquet, A., Pacheco, L. G. C., Alcantara-Neves, N. M., & Pinheiro, C. S. (2024). Therapeutic potential of a novel hybrid protein: Mitigating allergy and airway remodeling in chronic asthma models induced by Dermatophagoides pteronyssinus. Molecular Immunology, 175, 121-131. https://doi.org/10.1016/j.molimm.2024.09.005
Vancouver
Fernandes AMS, da Silva ES, Silva RC, Silveira EF, Santiago LF, de Andrade Belitardo EMM, et al. Therapeutic potential of a novel hybrid protein: Mitigating allergy and airway remodeling in chronic asthma models induced by Dermatophagoides pteronyssinus. Molecular Immunology. 2024;175:121-131. doi:10.1016/j.molimm.2024.09.005
BibTeX
@article{Fernandes2024,
author = {Fernandes, Antônio Márcio Santana and da Silva, Eduardo Santos and Silva, Raphael Chagas and Silveira, Elisânia Fontes and Santiago, Leonardo Freire and de Andrade Belitardo, Emília Maria Medeiros and Alves, Vítor Dos Santos and Bôas, Deise Souza Vilas and de Freitas, Luiz Antônio Rodrigues and Ferreira, Fatima and Jacquet, Alain and Pacheco, Luis Gustavo Carvalho and Alcantara-Neves, Neuza Maria and Pinheiro, Carina Silva},
title = {Therapeutic potential of a novel hybrid protein: Mitigating allergy and airway remodeling in chronic asthma models induced by Dermatophagoides pteronyssinus},
journal = {Molecular Immunology},
year = {2024},
volume = {175},
pages = {121--131},
doi = {10.1016/j.molimm.2024.09.005}
}
EUVIMED